[DRAFT] Breast Implant Risk Management Framework
Overview
The Therapeutic Goods Administration (TGA) is seeking comments on a proposed Breast Implant Risk Management Framework. The draft framework describes how the TGA identify, communicate and manage the risks associated with breast implants and what patients can do.
Why your views matter
The draft framework was developed to ensure that healthcare practitioners and patients have a shared understanding of the potential risks associated with breast implants, enabling informed decision making, enhanced patient safety and continuous improvement in breast implant-related procedures. We encourage you to share your feedback during this consultation. Your input is instrumental in refining the framework, and in ensuring that the framework reflects the needs and expectations of the public.
Audiences
- Aboriginal and Torres Strait Islander People
- Seniors
- Men
- Women
- Carers and guardians
- Families
- Parents
- Young people
- Academics
- Consumers
- Non-government organisations
- State government agencies
- Commonwealth agencies
- Health professionals
- Health workforce
- General public
- Community groups
- Businesses
- Contracted Service Providers
- Aged care service providers
- Aged care workforce
- Aged care professionals
- Industry
- Sponsors
- Manufacturers
- BPRU staff
- Graduates
- Online and Publications staff
- Secretariat
- PCCD
- Health staff
- HPRG (TGA) Staff
- Prescription medicines
- Complementary medicines
- Over-the-counter medicines
- Medical Devices & IVDs
- Biologicals
- Other
Interests
- Regulatory policy
Share
Share on Twitter Share on Facebook